V Square Quantitative Management LLC decreased its position in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 7.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 3,125 shares of the company’s stock after selling 236 shares during the quarter. V Square Quantitative Management LLC’s holdings in Cardinal Health were worth $370,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Eastern Bank purchased a new stake in Cardinal Health in the 3rd quarter valued at about $25,000. Frazier Financial Advisors LLC grew its holdings in shares of Cardinal Health by 69.8% during the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock worth $28,000 after purchasing an additional 104 shares during the period. Hara Capital LLC purchased a new stake in shares of Cardinal Health during the 3rd quarter worth about $31,000. AM Squared Ltd acquired a new position in shares of Cardinal Health in the 3rd quarter valued at approximately $33,000. Finally, Kentucky Trust Co acquired a new position in shares of Cardinal Health in the 4th quarter valued at approximately $41,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.
Wall Street Analyst Weigh In
Several equities research analysts recently issued reports on CAH shares. Deutsche Bank Aktiengesellschaft upped their price target on Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Wells Fargo & Company upped their price target on Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 4th. Evercore ISI raised Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price target on the stock in a research report on Tuesday, January 7th. TD Cowen raised Cardinal Health from a “hold” rating to a “buy” rating and upped their price target for the company from $130.00 to $144.00 in a research report on Wednesday, January 8th. Finally, Morgan Stanley upped their price target on Cardinal Health from $136.00 to $142.00 and gave the company an “overweight” rating in a research report on Friday, January 31st. Four equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and a consensus price target of $136.87.
Cardinal Health Stock Performance
NYSE:CAH opened at $126.35 on Monday. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $132.84. The stock has a market cap of $30.52 billion, a price-to-earnings ratio of 23.57, a PEG ratio of 1.49 and a beta of 0.63. The business has a fifty day moving average of $122.85 and a 200-day moving average of $116.41.
Cardinal Health (NYSE:CAH – Get Free Report) last released its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, equities research analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.
Cardinal Health Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a $0.5056 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 annualized dividend and a dividend yield of 1.60%. Cardinal Health’s payout ratio is 37.69%.
Cardinal Health Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Read More
- Five stocks we like better than Cardinal Health
- 3 Fintech Stocks With Good 2021 Prospects
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- Earnings Per Share Calculator: How to Calculate EPS
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- What Are the U.K. Market Holidays? How to Invest and Trade
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.